Last reviewed · How we verify
Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
The purpose of this study is to evaluate the efficacy and safety of ONO-8025 (KRP-197) in patients with overactive bladder.
Details
| Lead sponsor | Ono Pharmaceutical Co., Ltd. |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 750 |
| Start date | 2003-10 |
Conditions
- Overactive Bladder
Interventions
- ONO-8025 (KRP-197)
Primary outcomes
- Total number of urinary incontinence episodes per week